In the BioHarmony Drug Report Database

"Preview" Icon

Omadacycline

Nuzyra (omadacycline) is a small molecule pharmaceutical. Omadacycline was first approved as Nuzyra on 2018-10-02. It is used to treat bacterial infections, bacterial pneumonia, and bacterial skin diseases in the USA. Nuzyra’s patents are valid until 2037-10-31 (FDA).

 

Trade Name

 

Nuzyra
 

Common Name

 

omadacycline
 

ChEMBL ID

 

CHEMBL1689772
 

Indication

 

bacterial infections, bacterial pneumonia, bacterial skin diseases
 

Drug Class

 

Antibiotics (tetracycline derivatives)

Image (chem structure or protein)

Omadacycline structure rendering